Background Tuberculosis (TB) is the world's leading infectious cause of death.
Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over …

Background Accurate, rapid detection of tuberculosis (TB) and TB drug resistance is critical
for improving patient care and decreasing TB transmission. Xpert® MTB/RIF assay is an …

Background Xpert MTB/RIF and Xpert MTB/RIF Ultra (Xpert Ultra) are World Health
Organization (WHO)‐recommended rapid tests that simultaneously detect tuberculosis and …

Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the
newest version, are the only World Health Organization (WHO)‐recommended rapid tests …

Background Xpert MTB/RIF Ultra (Xpert Ultra) and Xpert MTB/RIF are World Health
Organization (WHO)‐recommended rapid nucleic acid amplification tests (NAATs) widely …

Background The World Health Organization (WHO) End TB Strategy stresses universal
access to drug susceptibility testing (DST). DST determines whether Mycobacterium …

BACKGROUND: Xpert® MTB/RIF is a commercially available nucleic acid amplification test
developed for the diagnosis of pulmonary tuberculosis (PTB). OBJECTIVE: To determine the …

Xpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) is endorsed for the detection of pulmonary
tuberculosis (TB). We performed a systematic review and meta-analysis to assess the …

Abstract Objectives The re-engineered Xpert MTB/RIF Ultra (Xpert Ultra) assay was
developed due to the poor sensitivity of the Xpert MTB/RIF assay for the detection of …

Summary Background Xpert MTB/RIF, the most widely used automated nucleic acid
amplification test for tuberculosis, is available in more than 130 countries. Although …